Table of Contents
For nearly a decade, the most valuable financial institution India never let you buy a piece of was the very exchange on which almost every share you do own is traded. That is about to change.
On 17 June 2026, NSE filed its DRHP with SEBI, the formal first step of an IPO that has been talked about, delayed, litigated, and rumoured since 2016. The estimated issue size of the NSE IPO is around ₹30,000 crore. NSE IPO is positioned to become the largest IPO in Indian history, surpassing Hyundai Motor India’s ₹27,858.80 crore record set in 2024.
Here is everything the draft prospectus actually tells us, and just as importantly, what it does not.
Dominance of NSE in Indian Markets
To understand why this listing matters, look at how much of the Indian market simply is NSE. As per its DRHP disclosures, NSE commands roughly 93% of cash-market turnover, 99.79% of equity futures, and 74.71% of equity options by premium. In currency derivatives, its share is 99.48% in futures and effectively 100% in options. It serves over 12.9 crore (129 million) registered unique investors.
The dominance is global, not just domestic. NSE ranks #1 worldwide in equity derivatives contracts traded (about 51% global share) and #3 in the number of cash-equity trades.
This is not a company competing for market share. It is the infrastructure on which the competition runs.
NSE IPO: Key Details from DRHP
Here is what the draft prospectus confirms, as of June 2026:
- Issue type: 100% Offer for Sale (OFS). No fresh issue. The DRHP lists – ‘Fresh Issue: Not applicable.’
- Offer size: Up to 148,905,525 equity shares, roughly 6.02% of the company.
- Estimated issue value: ₹25,000-30,000 crore, based on indicative valuations.
- Listing venue: BSE only. Regulation bars an exchange from listing on its own platform.
- Lead managers: A syndicate of 20 Book Running Lead Managers, including Kotak Mahindra Capital, JM Financial, Morgan Stanley, J.P. Morgan, HSBC, Citi, Axis Capital, ICICI Securities, and SBI Capital Markets among the largest banker line-ups ever assembled for an Indian issue.
- Registrar: MUFG Intime India.
- Promoter: None. NSE has no identifiable promoter, unusual for a systemically important institution.
On price, dates, and GMP: the price band, final issue size, and IPO calendar will only be announced after SEBI issues its observations and NSE files the Red Herring Prospectus (RHP). Because the issue is still at the DRHP stage, there is no official Grey Market Premium (GMP) yet. Unlisted NSE shares have been changing hands in the private market at roughly ₹1950-2050, which offers a rough read on sentiment but is not a published GMP. Treat any NSE GMP figure circulating before the RHP as speculation.
Suggested Read: How StockEdge Simplifies Investing in IPOs
NSE IPO Objectives
Here is the part many first-time applicants miss:
NSE will not receive a single rupee from this IPO.
Because the entire issue is an OFS, every paisa of the proceeds goes to the selling shareholders, not the company. NSE is not raising growth capital. It has a strong balance sheet and funds for expansion internally. The listing exists to give long-standing investors an exit and to bring a marquee institution into public ownership.
This is an ownership-change event, not a fundraiser.
The 10-Year Journey of the NSE IPO
NSE first approved an IPO via OFS back in 2016. So why has it taken almost ten years?
The answer is the co-location controversy. Allegations that certain brokers got preferential, faster access to NSE’s trading servers, alongside related governance and legal matters. These kept the regulator’s clearance on hold for years.
The logjam finally broke in 2026. SEBI Chairman Tuhin Kanta Pandey publicly signalled clearance in early January, and on 30 January 2026 SEBI issued its NOC, the mandatory green light for any market-infrastructure institution. From there the process moved fast. Board approval in February, 20 lead managers appointed by March, shareholder tendering through April, and the DRHP filed on 17 June 2026. NSE is targeting a listing before December 2026.
Who Is Selling Shares in the IPO?
The OFS is a roll-call of India’s financial establishment cashing in early bets.
State Bank of India is the single largest seller, offering up to 2.48 crore shares. Stock Holding Corporation of India is offloading about 1.08 crore shares, with MS Strategic (Mauritius), Morgan Stanley, the Canada Pension Plan Investment Board, Bank of Baroda, and various insurers and global investors also participating.
Notably, some big names are staying put: Life Insurance Corporation (LIC) is the largest single shareholder at around 10.72% along with Premji Invest and investor Radhakishan Damani, who are not selling.
Why Are Existing Investors Cashing Out?
For these holders, the maths is good. Many institutional shareholders acquired NSE stock at costs of well under ₹1 per share. Against an unlisted valuation now near ₹5 lakh crore, the IPO represents a multi-thousand-fold return on capital deployed years ago.
That said, the partial nature of the selling matters. SBI is trimming, not exiting. LIC isn’t selling at all. When sophisticated long-term owners book some gains while retaining most of their stake, it usually signals profit-taking on a strong asset not a loss of faith in it.
NSE’s Financial Performance
NSE is one of the most profitable businesses in India. It is also, for the first time in years, a business that has just printed a decline.
Per the DRHP:
- FY26 Revenue from operations: ₹16,601.31 crore down 3.1% from ₹17,140.68 crore in FY25.
- FY26 Profit After Tax: ₹10,302.06 crore down 15.5% from ₹12,188 crore in FY25.
- Net profit margin (FY26): 55.05%.
- Adjusted operating EBITDA margin (FY26): 75.48%.
- Return on Equity: 32.98% among the highest of any listed exchange globally.
- Revenue CAGR (FY22–FY26): 20.5%.
The dip was driven mainly by lower transaction and clearing income as derivatives volumes moderated following SEBI’s F&O curbs. For context, a Nasdaq-style global peer runs net margins around 21%. NSE is 55% underlines just how high-margin a dominant exchange can be. The board also recommended a final dividend of ₹35 per share, including a special one-time component.
Understanding the Valuation of NSE
At a valuation around ₹5 lakh crore against FY26 PAT of ₹10,302 crore, NSE would list at a price-to-earnings multiple in the high-40s.
Is that expensive? It depends on your lens. For a near-monopoly with 55% net margins, 32% ROE, and structural tailwinds from India’s expanding investor base, premium pricing is defensible. But the FY26 earnings decline is a reminder that even monopolies are not immune to regulation. The final verdict will only be possible once the RHP sets the actual price band, which is why valuation, not hype, deserves the most attention when that number lands.
Key Risks to Watch
A few risks stand out in the DRHP and surrounding data:
1. Heavy reliance on options. With 75% share of equity options, NSE is highly exposed to SEBI’s derivatives tightening true-to-label charges, fewer weekly expiries, and larger lot sizes. These very measures caused FY26’s revenue and profit to dip.
2. The retail F&O reality. SEBI’s July 2025 study found that over 91% of individual F&O traders lost money in FY25, with aggregate net losses of ₹1,05,603 crore, and unique F&O traders falling 20%. Continued regulatory pressure on this segment is a direct headwind to NSE’s largest profit pool.
3. Governance and structure. The legacy co-location matters, past board-composition issues, and the absence of an identifiable promoter all feature in the risk section.
4. Reliance on exceptional items. FY26 profitability was supported in part by a one-time pre-tax gain from the sale of NSE’s stake in NSDL, worth scrutinising when assessing recurring earnings.
5. Competition. BSE has been steadily gaining ground in select derivatives segments.
Conclusion
The NSE IPO is a genuine landmark, a chance to own equity in the engine room of Indian capital markets, backed by world-class margins and an entrenched position. But it arrives with three asterisks that every applicant should internalise. It is a pure OFS (no capital reaches the company), it follows a rare year of declining earnings, and its biggest profit centre sits squarely in SEBI’s regulatory crosshairs. Any meaningful IPO analysis should focus on valuation, earnings quality, and regulatory risks rather than market excitement.
The smart approach is the patient one. Wait for the RHP, study the final price band against FY26 earnings rather than against GMP chatter, and read the risk factors as carefully as the strengths. A great institution and a great investment are not always the same thing. The difference is usually decided by price.
Suggested Read: NSE’s 30 Years Journey
FAQs
1. Will NSE shares be listed on its own exchange after the IPO?
No. Indian regulations prohibit a stock exchange from listing its own shares on its own platform. NSE shares will be listed on the BSE instead.
2. Is the NSE IPO a fresh issue or an Offer for Sale?
It is a 100% Offer for Sale (OFS). There is no fresh issue of shares, and NSE itself will not receive any of the proceeds. All funds go to the selling shareholders.
3. Who are the major shareholders selling stakes in the IPO?
State Bank of India is the largest seller up to 2.48 crore shares, followed by Stock Holding Corporation of India, MS Strategic, Morgan Stanley, the Canada Pension Plan Investment Board, Bank of Baroda, and other institutions.
